Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Famous Network programs in Europe and America - 2Extreme Manual for Purchasing Your Next Truck
- 3FACT FOCUS: Trump sows confusion on number of childhood vaccinations
- 4Find the Historical backdrop of the Modern Unrest: Changing Society and Innovation
- 5Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- RFK Jr. wants to scrutinize the vaccine schedule – but its safety record is already decades long
- What's your #1 tone
- Court clears Beersheba assault suspect of link to Haymanut Kasau disappearance, extends detention
- Monetary Strengthening: Assuming Command over Your Cash
- California warns of death cap mushrooms outbreak resulting in 3 deaths
- IDF bans Android phones for senior officers, iPhones now mandatory, Army Radio reports
- People are getting their news from AI – and it’s altering their views
- Best Augmented Simulation Ride: Which One Feels Generally Genuine?
- Manual for Tracking down Spending plan Agreeable Travel Objections
